# DCP- Cancer Immunoprevention Laboratory Support

> **NIH NIH N01** · LEIDOS BIOMEDICAL RESEARCH, INC. · 2022 · $3,110,360

## Abstract

Establish a new Cancer Immunoprevention Laboratory – Dedicated to DCP and serve as a reference lab confirming key results from Task order contractors using standardize methods and performing work to advance successful immunoprevention concepts in preclinical development.

## Key facts

- **NIH application ID:** 10658819
- **Project number:** 75N91019D00024-P00018-759102000003-36
- **Recipient organization:** LEIDOS BIOMEDICAL RESEARCH, INC.
- **Principal Investigator:** LEONARD FREEDMAN
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $3,110,360
- **Award type:** —
- **Project period:** 2020-08-31 → 2022-08-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10658819

## Citation

> US National Institutes of Health, RePORTER application 10658819, DCP- Cancer Immunoprevention Laboratory Support (75N91019D00024-P00018-759102000003-36). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10658819. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*